ICESP - INSTITUTO DO CÂNCER DO ESTADO DE SÃO PAULO (Site 0302)

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Lung cancer

Running trials

• Recruiting

  Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  NCT06422143· Phase 3· Merck Sharp & Dohme LLC· Source

  Contact: Study Coordinator

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Lung cancer1 recruiting